Terms: = Uterine cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Prognosis
4 results:
1. SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.
Penolazzi L; Bonaccorsi G; Gafà R; Ravaioli N; Gabriele D; Bosi C; Lanza G; Greco P; Piva R
Gene; 2019 Aug; 711():143938. PubMed ID: 31220580
[TBL] [Abstract] [Full Text] [Related]
2. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
[TBL] [Abstract] [Full Text] [Related]
3. Lymphovascular Space Invasion for Endometrial cancer: Undertreatment and Overtreatment Risks: A Survey of the Spanish Gynecologic Oncology Group.
Gorostidi Pulgar M; Diaz de la Noval B; Gil-Ibañez B; Lago Leal V; Jaunarena Marin I; Padilla Iserte P
Int J Gynecol Cancer; 2017 Jul; 27(6):1191-1199. PubMed ID: 28557833
[TBL] [Abstract] [Full Text] [Related]
4. Cervical cancer: women aged 35 and younger compared to women aged 36 and older.
Clark MA; Naahas W; Markert RJ; Dodson MG
Am J Clin Oncol; 1991 Aug; 14(4):352-6. PubMed ID: 1862767
[TBL] [Abstract] [Full Text] [Related]
